Wexford Laboratories Private Limited — Omeprazole Exporter Profile
Indian Pharmaceutical Exporter · #14 for Omeprazole · $5.0M export value · DGFT Verified
Wexford Laboratories Private Limited is the #14 Indian exporter of Omeprazole with $5.0M in export value and 100 verified shipments. Wexford Laboratories Private Limited holds a 0.8% market share in Omeprazole exports across 8 countries. The company exports 11 pharmaceutical products worth $31.5M across 7 therapeutic categories.
Wexford Laboratories Private Limited — Omeprazole Export Profile: Buyers & Destinations
Where Does Wexford Laboratories Private Limited Export Omeprazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ECUADOR | $632.0K | 58 | 51.8% |
| HONDURAS | $171.1K | 26 | 14.0% |
| NICARAGUA | $167.2K | 25 | 13.7% |
| DOMINICAN REPULIC | $111.0K | 24 | 9.1% |
| EL SALVADOR | $65.0K | 14 | 5.3% |
| DOMINICAN REPUBLIC | $32.5K | 8 | 2.7% |
| BOLIVIA | $16.8K | 3 | 1.4% |
| GAUTEMALA | $10.7K | 2 | 0.9% |
| PANAMA | $8.0K | 3 | 0.7% |
| GUATEMALA | $6.5K | 1 | 0.5% |
Wexford Laboratories Private Limited exports Omeprazole to 10 countries. The largest destination is ECUADOR accounting for 51.8% of Wexford Laboratories Private Limited's Omeprazole shipments, followed by HONDURAS (14.0%) and NICARAGUA (13.7%). These destinations reflect Wexford Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Omeprazole from Wexford Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DYVENPRO DISTRIBUCION Y VENTA DE | ECUADOR | $590.2K | 56 |
| DROGUERIA AMERICANA S.A.DE C.V | HONDURAS | $120.8K | 14 |
| PHARBUS, S.A. | NICARAGUA | $68.5K | 3 |
| PHARBUS S A | NICARAGUA | $61.0K | 2 |
| PHARMAMAXX CORP,SRL | DOMINICAN REPULIC | $47.9K | 8 |
| PHARMAONE S. A. | ECUADOR | $41.7K | 2 |
| DROGUERIA Y LABORATORIO AMERICAN | NICARAGUA | $33.7K | 18 |
| LABORATORIOS ALFA S. A. | BOLIVIA | $16.8K | 3 |
| LABORATORIOS SUIZOS S.A DE C.V | EL SALVADOR | $16.5K | 5 |
| GUARDADO S A DE C V | EL SALVADOR | $15.2K | 2 |
Wexford Laboratories Private Limited supplies Omeprazole to 41 buyers globally. The largest buyer is DYVENPRO DISTRIBUCION Y VENTA DE (ECUADOR), followed by DROGUERIA AMERICANA S.A.DE C.V (HONDURAS) and PHARBUS, S.A. (NICARAGUA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Omeprazole Export Value and How Much Does Wexford Laboratories Private Limited Contribute?
India exported $248.0M worth of Omeprazole through 15,000 shipments from 975 suppliers to 179 countries, serving 2,858 buyers globally. Wexford Laboratories Private Limited contributes $5.0M to this total, accounting for 0.8% of India's Omeprazole exports. Wexford Laboratories Private Limited ships Omeprazole to 10 countries through 41 buyers.
What Is the Average Shipment Value for Wexford Laboratories Private Limited's Omeprazole Exports?
Wexford Laboratories Private Limited's average Omeprazole shipment value is $50.0K per consignment, based on 100 shipments totaling $5.0M. The largest destination is ECUADOR (51.8% of Wexford Laboratories Private Limited's Omeprazole exports).
How Does Wexford Laboratories Private Limited Compare to Other Indian Omeprazole Exporters?
Wexford Laboratories Private Limited ranks #14 among 975 Indian Omeprazole exporters with a 0.8% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($53.6M), CIPLA LIMITED ($44.0M), DR.REDDY'S LABORATORIES LTD ($35.7M). Wexford Laboratories Private Limited processed 100 shipments to 8 destination countries.
What Omeprazole Formulations Does Wexford Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OMEPRAZOLE DELAYED - RELEASE CAPSULES US | $510.0K | 26 |
| OMEPRAZOLE FOR INJECTION 40MG | $113.2K | 12 |
| OMEPRAZOLE DELAYED - RELEASE CAPSULES USP, 20MG - LANZOACID | $77.7K | 6 |
| OMEPRAZOLE DELAYED - RELEASE CAPSULES USP 20MG | $33.4K | 3 |
| OMEPRAZOLE DELAYED-RELEASE CAPSULES USP | $30.9K | 4 |
| OMEPRAZOLE DELAYED-RELEASE CAPSULES USP,20MG-LANZOACID | $25.9K | 3 |
| ESOMEPRAZOLE CAPSULES 40MG-NEXIL | $22.6K | 4 |
| OMEPRAZOLE FOR INJECTION 40MG76740NOS0.2719 | $20.9K | 1 |
| OMEPRAZOLE FOR INJECTION 40MG76790NOS0.2717 | $20.9K | 1 |
| AMOXICILLIN TABLET 1G +LEVOFLOXACIN TABLETS 750MG+ ESOMEPRAZOLE CAPSULES 40MG- EZOMAXX HP-(B/10X7) | $19.7K | 1 |
Wexford Laboratories Private Limited exports 75 distinct Omeprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OMEPRAZOLE DELAYED - RELEASE CAPSULES US with 26 shipments worth $510.0K.
How Does Wexford Laboratories Private Limited Compare to Nearest Omeprazole Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | CAPLIN POINT LABORATORIES LIMITED | $5.1M | 135 | 10 | $37.9K |
| 11 | BIOCON PHARMA LIMITED | $5.0M | 101 | 1 | $50.0K |
| 14 | WEXFORD LABORATORIES PRIVATE LIMITED ★ | $5.0M | 100 | 8 | $50.0K |
Wexford Laboratories Private Limited ranks #14 among 975 Indian Omeprazole exporters. Average shipment value of $50.0K compared to the market average of $254.4K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and BIOCON PHARMA LIMITED.
Which Indian Ports Ship Omeprazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,900 | 12.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,316 | 8.8% |
| DELHI AIR CARGO ACC (INDEL4) | 857 | 5.7% |
| SAHAR AIR | 837 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 784 | 5.2% |
| HYDERABAD ICD (INSNF6) | 480 | 3.2% |
| Bombay Air | 463 | 3.1% |
| DELHI AIR | 456 | 3.0% |
About Wexford Laboratories Private Limited
Wexford Laboratories Private Limited exports 11 products worth $31.5M. Beyond Omeprazole, top products include Amoxicillin, Ibuprofen, Loratadine, Enalapril, Clarithromycin. View the complete Wexford Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Omeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Omeprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Wexford Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 164 individual customs records matching Wexford Laboratories Private Limited exporting Omeprazole, covering 75 formulations to 10 countries via 41 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 179+ countries, 2,858+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Omeprazole Export Data from Wexford Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Wexford Laboratories Private Limited's Omeprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Wexford Laboratories Private Limited
Full Company Profile →
11 products · $31.5M total trade · 7 categories
Omeprazole Stats
Company Overview
Top Products by Wexford Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Wexford Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Omeprazole. For current shipment-level data, contact TransData Nexus.